BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 19648253)

  • 1. Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning.
    Vessey DA; Li L; Honbo N; Karliner JS
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1429-35. PubMed ID: 19648253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2X7 receptor agonists pre- and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1/P2X₇ channels.
    Vessey DA; Li L; Kelley M
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H881-7. PubMed ID: 21685263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine protects aging hearts from ischemia/reperfusion injury: Superiority to sphingosine 1-phosphate and ischemic pre- and post-conditioning.
    Vessey DA; Kelley M; Li L; Huang Y
    Oxid Med Cell Longev; 2009; 2(3):146-51. PubMed ID: 20592769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
    Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
    Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioning.
    Vessey DA; Li L; Imhof I; Honbo N; Karliner JS
    Med Sci Monit Basic Res; 2013 Apr; 19():126-32. PubMed ID: 23567658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury.
    Means CK; Xiao CY; Li Z; Zhang T; Omens JH; Ishii I; Chun J; Brown JH
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2944-51. PubMed ID: 17293497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine can pre- and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate.
    Vessey DA; Li L; Kelley M; Zhang J; Karliner JS
    J Biochem Mol Toxicol; 2008; 22(2):113-8. PubMed ID: 18418901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine 1-Phosphate Postconditioning Protects Against Myocardial Ischemia/reperfusion Injury in Rats via Mitochondrial Signaling and Akt-Gsk3β Phosphorylation.
    Fang R; Zhang LL; Zhang LZ; Li W; Li M; Wen K
    Arch Med Res; 2017 Feb; 48(2):147-155. PubMed ID: 28625317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
    Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic preconditioning requires opening of pannexin-1/P2X(7) channels not only during preconditioning but again after index ischemia at full reperfusion.
    Vessey DA; Li L; Kelley M
    Mol Cell Biochem; 2011 May; 351(1-2):77-84. PubMed ID: 21267638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury.
    Jin ZQ; Zhang J; Huang Y; Hoover HE; Vessey DA; Karliner JS
    Cardiovasc Res; 2007 Oct; 76(1):41-50. PubMed ID: 17610857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary role of extracellular ATP and adenosine in ischemic preconditioning in the rat heart.
    Ninomiya H; Otani H; Lu K; Uchiyama T; Kido M; Imamura H
    Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1810-20. PubMed ID: 11959647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remote cardioprotection by transfer of coronary effluent from ischemic preconditioned rabbit heart preserves mitochondrial integrity and function via adenosine receptor activation.
    Leung CH; Wang L; Nielsen JM; Tropak MB; Fu YY; Kato H; Callahan J; Redington AN; Caldarone CA
    Cardiovasc Drugs Ther; 2014 Feb; 28(1):7-17. PubMed ID: 24018748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role and related mechanism of S1P/S1P1 signal pathway during post conditioning of hypertrophic cardiomyocytes].
    Bao XH; Li HX; Tao J; Li XM; Yang YN; Ma YT; Chen BD
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 May; 44(5):431-5. PubMed ID: 27220580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remote postconditioning by humoral factors in effluent from ischemic preconditioned rat hearts is mediated via PI3K/Akt-dependent cell-survival signaling at reperfusion.
    Breivik L; Helgeland E; Aarnes EK; Mrdalj J; Jonassen AK
    Basic Res Cardiol; 2011 Jan; 106(1):135-45. PubMed ID: 21103992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.
    Ruze A; Chen BD; Liu F; Chen XC; Gai MT; Li XM; Ma YT; Du XJ; Yang YN; Gao XM
    Clin Sci (Lond); 2019 Mar; 133(5):665-680. PubMed ID: 30804219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine kinase and sphingosine 1-phosphate in cardioprotection.
    Karliner JS
    J Cardiovasc Pharmacol; 2009 Mar; 53(3):189-97. PubMed ID: 19247197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y
    Audia JP; Yang XM; Crockett ES; Housley N; Haq EU; O'Donnell K; Cohen MV; Downey JM; Alvarez DF
    Basic Res Cardiol; 2018 Jul; 113(5):32. PubMed ID: 29992382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning.
    Vessey DA; Li L; Jin ZQ; Kelley M; Honbo N; Zhang J; Karliner JS
    Oxid Med Cell Longev; 2011; 2011():961059. PubMed ID: 21904650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of contractile activity during postconditioning enhances cardioprotection by restoring sarcolemmal dystrophin through phosphatidylinositol 3-kinase.
    Moriguchi A; Otani H; Yoshioka K; Shimazu T; Fujita M; Okazaki T; Sato D; Kyoi S; Iwasaka T
    Circ J; 2010 Nov; 74(11):2393-402. PubMed ID: 20877127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.